Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis
- PMID: 8621427
- DOI: 10.1074/jbc.271.10.5638
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis
Abstract
Vascular endothelial growth factor (VEGF) expression in various cell types is induced by hypoxia and other stimuli. VEGF mediates endothelial cell proliferation, angiogenesis, vascular growth, and vascular permeability via the endothelial cell receptors, kinase insert domain-containing receptor (KDR)/fetal liver kinase 1 (Flk-1) and FLT-1. Alanine-scanning mutagenesis was used to identify a positively charged surface in VEGF that mediates binding to KDR/Flk-1. Arg82, Lys84 and His86, located in a hairpin loop, were found to be critical for binding KDR/Flk-1, while negatively charged residues, Asp63, Glu64, and Glu67, were associated with FLT-1 binding. A VEGF model based on PDGFb indicated these positively and negatively charged regions are distal in the monomer but are spatially close in the dimer. Mutations within the KDR site had minimal effect on FLT-1 binding, and mutants deficient in FLT-1 binding did not affect KDR binding. Endothelial cell mitogenesis was abolished in mutants lacking KDR affinity; however, FLT-1 deficient mutants induced normal proliferation. These results suggest dual sets of determinants in the VEGF dimer that cross-link cell surface receptors, triggering endothelial cell growth and angiogenesis. Furthermore, this mutational analysis implicates KDR, but not FLT-1, in VEGF induction of endothelial cell proliferation.
Similar articles
-
Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.Cell Growth Differ. 1996 Feb;7(2):213-21. Cell Growth Differ. 1996. PMID: 8822205
-
Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.Cancer Res. 2001 Oct 1;61(19):7002-8. Cancer Res. 2001. PMID: 11585724
-
Characterization of the VEGF binding site on the Flt-1 receptor.Biochem Biophys Res Commun. 1999 Sep 7;262(3):731-8. doi: 10.1006/bbrc.1999.1282. Biochem Biophys Res Commun. 1999. PMID: 10471394
-
Vascular endothelial growth factor.Int J Biochem Cell Biol. 1998 Nov;30(11):1169-74. doi: 10.1016/s1357-2725(98)00082-x. Int J Biochem Cell Biol. 1998. PMID: 9839443 Review.
-
Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family.Cardiovasc Res. 2001 Feb 16;49(3):568-81. doi: 10.1016/s0008-6363(00)00268-6. Cardiovasc Res. 2001. PMID: 11166270 Review.
Cited by
-
Vascular endothelial growth factor receptor-2: its unique signaling and specific ligand, VEGF-E.Cancer Sci. 2003 Sep;94(9):751-6. doi: 10.1111/j.1349-7006.2003.tb01514.x. Cancer Sci. 2003. PMID: 12967471 Free PMC article. Review.
-
Piceatannol, a Natural Analog of Resveratrol, Exerts Anti-angiogenic Efficiencies by Blockage of Vascular Endothelial Growth Factor Binding to Its Receptor.Molecules. 2020 Aug 19;25(17):3769. doi: 10.3390/molecules25173769. Molecules. 2020. PMID: 32824997 Free PMC article.
-
Specific humoral response in cancer patients treated with a VEGF-specific active immunotherapy procedure within a compassionate use program.BMC Immunol. 2020 Mar 14;21(1):12. doi: 10.1186/s12865-020-0338-4. BMC Immunol. 2020. PMID: 32171254 Free PMC article.
-
Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis.Bioeng Transl Med. 2017 Mar;2(1):81-91. doi: 10.1002/btm2.10051. Epub 2017 Feb 17. Bioeng Transl Med. 2017. PMID: 28516164 Free PMC article.
-
A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics.Molecules. 2021 Nov 9;26(22):6759. doi: 10.3390/molecules26226759. Molecules. 2021. PMID: 34833851 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources